Depression is more than feeling sad or going through a difficult period. It is a psychiatric condition that can affect mood, energy, motivation, concentration, sleep, appetite, relationships, and the ability to experience interest or enjoyment. For some individuals, even routine responsibilities at work or home become difficult, while activities that once provided meaning or satisfaction become harder to engage in.
Depression does not look the same in everyone. Some people experience persistent sadness, while others notice emotional numbness, irritability, fatigue, impaired concentration, changes in sleep or appetite, loss of motivation, feelings of worthlessness or guilt, or diminished interest in activities.
These symptoms are not specific to depression. Similar concerns can occur with bipolar disorder, anxiety disorders, ADHD, trauma-related disorders, substance use, sleep disorders, medication effects, and medical conditions. A depressive episode can also occur as part of bipolar disorder. Accurate diagnosis is therefore the foundation of effective treatment.
At BeyondBridge, depression is approached through comprehensive psychiatric evaluation, diagnostic precision, and individualized treatment planning. Rather than focusing only on symptom reduction, the evaluation seeks to understand the longitudinal course of illness, contributing psychiatric and medical factors, previous treatment response, and the impact of symptoms on overall functioning.
Understanding Treatment-Resistant Depression
Many individuals with depression improve with treatment, while others continue to experience significant symptoms despite appropriate care.
Treatment-resistant depression (TRD) is commonly used to describe major depressive disorder that has not responded adequately to at least two antidepressant treatment trials of adequate dose and duration, although definitions vary across research and clinical practice.
The term should not be applied solely because someone has taken several medications. Before concluding that depression is treatment-resistant, careful reassessment may include whether the original diagnosis remains accurate, whether previous treatments were adequate in dose and duration, whether medications were taken consistently, and whether co-occurring psychiatric, medical, sleep, substance-related, or psychosocial factors are contributing to persistent symptoms.
Bipolar disorder is an especially important diagnostic consideration when depression has not responded as expected. Persistent depressive symptoms can also reflect partial treatment response, residual symptoms, medication tolerability problems, or a more complex clinical presentation rather than treatment resistance alone.
Treatment resistance does not mean that meaningful improvement is no longer possible. Instead, it signals the need to reconsider the clinical formulation, reconstruct previous treatment systematically, and determine which evidence-based strategies remain appropriate.
Comprehensive Depression Evaluation
A comprehensive evaluation considers more than the presence or absence of depressive symptoms. It examines how symptoms developed, how the illness has evolved, which treatments have already been tried, and what factors may be influencing recovery.
Each comprehensive evaluation may include:
- Comprehensive psychiatric and medical history
- Detailed review of current symptoms and previous depressive episodes
- Assessment of symptom severity, duration, recurrence, and functional impairment
- Evaluation for previous mania, hypomania, mixed symptoms, or other features suggesting bipolar disorder
- Assessment for anxiety disorders, ADHD, trauma-related disorders, substance use, sleep disorders, and other co-occurring psychiatric conditions
- Review of medical conditions, medications, substances, and other factors that may contribute to depressive symptoms
- Assessment of occupational functioning, relationships, motivation, cognition, and day-to-day responsibilities
- Detailed reconstruction of previous antidepressant trials, including dose, duration, adherence, effectiveness, tolerability, and reasons for discontinuation
- Review of previous psychotherapy and other psychiatric treatments
- Assessment of safety, including suicidal thoughts or behavior when clinically indicated
- Review of prior records and collateral information when clinically appropriate and available
- Use of validated symptom measures when clinically appropriate to characterize severity and monitor treatment response
Standardized measures can help quantify depressive symptoms and track change over time, but scores alone do not determine the diagnosis or establish treatment resistance. They are most useful when interpreted alongside the clinical history, functional assessment, and treatment course.
The goal is to develop a comprehensive formulation that clarifies the diagnosis, identifies factors contributing to persistent symptoms, determines whether prior treatments were adequate, and guides the next treatment strategy.
Individualized Treatment
Depression treatment should be tailored to the individual rather than determined by a single algorithm. Treatment selection may depend on diagnosis, symptom profile, severity, medical history, co-occurring conditions, previous treatment response, tolerability, functional needs, and patient preferences.
Depending on clinical needs, treatment may include:
- Medication management when clinically appropriate
- Evidence-based psychotherapy
- Optimization of an existing treatment when appropriate
- Switching or augmentation strategies when clinically indicated
- Attention to sleep, physical activity, routines, and other health behaviors that may support recovery
- Treatment of co-occurring psychiatric or medical conditions
- Strategies addressing occupational, relationship, and functional consequences of depression
- Longitudinal monitoring of symptoms, functioning, effectiveness, tolerability, and changing clinical needs
Treatment decisions should reflect both symptom improvement and meaningful functioning. A reduction in a depression rating score can be important, but recovery may also involve renewed interest and motivation, clearer thinking, healthier relationships, improved occupational functioning, and greater participation in everyday life.
When Depression Persists
When appropriate treatment has not produced sufficient improvement, the next step is not necessarily another medication prescribed in isolation. Persistent depression often warrants a systematic review of diagnosis, previous treatments, co-occurring conditions, tolerability, adherence, and remaining therapeutic options.
For selected individuals with persistent or treatment-resistant depression, treatment strategies may include pharmacologic augmentation, Transcranial Magnetic Stimulation (TMS), ketamine or esketamine treatment, or Electroconvulsive Therapy (ECT), depending on the clinical circumstances.
These treatments differ substantially in indications, evidence, risks, practical requirements, and appropriateness for a particular patient. The number of previous treatment trials is only one consideration. Symptom severity, urgency, prior response, medical history, patient preferences, access, and the broader treatment history also matter.
The goal is not simply to accumulate additional treatments. It is to determine why previous treatment has been insufficient and identify the next intervention with a clinically meaningful rationale.
Functioning Beyond Symptom Reduction
Depression can affect cognition, motivation, relationships, professional responsibilities, and everyday functioning even when some symptoms have begun to improve. Symptomatic improvement and functional recovery are related but not identical.
For selected patients, Signature Specialty Psychiatry™ consultations may incorporate the BeyondBridge Functional Performance Assessment™ to better understand how depression affects attention, perceived cognitive functioning, motivation, occupational responsibilities, relationships, decision-making demands, and day-to-day functioning.
This assessment is intended to inform the clinical formulation and treatment strategy. It is not presented as a stand-alone diagnostic test for depression or as formal neuropsychological testing.
Treatment recommendations are developed through BeyondBridge Decision Navigation™, a physician-led shared decision-making process that helps patients understand the clinical formulation, available treatment options, expected benefits, potential risks, alternatives, and the reasoning behind each recommendation.
This collaborative approach supports treatment decisions that reflect available evidence together with each patient’s medical history, circumstances, values, and goals.
Our Philosophy
Depression is not defined by a single symptom, and persistent depression should not automatically be interpreted as evidence that available treatments have been exhausted.
Diagnostic precision requires understanding the nature and course of the depressive illness, considering alternative and co-occurring conditions, reconstructing previous treatment carefully, and identifying factors that may be contributing to ongoing symptoms.
Recovery is also about more than reducing a symptom score. Meaningful improvement may include restoring emotional well-being, motivation, cognitive clarity, relationships, professional functioning, and the capacity to experience meaning and satisfaction in everyday life.
At BeyondBridge, every treatment plan begins with careful diagnostic assessment, thoughtful clinical formulation, and care that is individualized, collaborative, and grounded in evidence.
Diagnostic Precision. Individualized Care.
This page is intended for general educational purposes and does not replace individualized psychiatric or medical evaluation.
References
- Sforzini L, et al. A Delphi-Method-Based Consensus Guideline for Definition of Treatment-Resistant Depression for Clinical Trials. Mol Psychiatry. 2022.
- McIntyre RS, et al. Treatment-Resistant Depression: Definition, Prevalence, Detection, Management, and Investigational Interventions. World Psychiatry. 2023.
- Gaddey HL, et al. Depression: Managing Resistance and Partial Response to Treatment. Am Fam Physician. 2024.
- Lam RW, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Can J Psychiatry. 2024.